Evaluation of guidelines for community-acquired pneumonia: a story of confounders, surprises and challenges Ewig S., Welte T. Eur Respir J 2008; 32: 823-825 | |
Alveolar permeability and stretch: too far, too fast Trepat X., Farre R. Eur Respir J 2008; 32: 826-828 | |
Lung function decline in COPD trials: bias from regression to the mean Suissa S. Eur Respir J 2008; 32: 829-831 | |
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Vanaudenaerde B. M., Meyts I., Vos R., Geudens N., De Wever W., Verbeken E. K., Van Raemdonck D. E., Dupont L. J., Verleden G. M. Eur Respir J 2008; 32: 832-842 | |
COPD-related morbidity and mortality after smoking cessation: status of the evidence Godtfredsen N. S., Lam T. H., Hansel T. T., Leon M. E., Gray N., Dresler C., Burns D. M., Prescott E., Vestbo J. Eur Respir J 2008; 32: 844-853 | |
Frequency and peak stretch magnitude affect alveolar epithelial permeability Cohen T. S., Cavanaugh K. J., Margulies S. S. Eur Respir J 2008; 32: 854-861 | |
The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury Geudens N., Van de Wouwer M., Vanaudenaerde B. M., Vos R., Van De Wauwer C., Verleden G. M., Verbeken E., Lerut T., Van Raemdonck D. E. M., Conway E. M. Eur Respir J 2008; 32: 862-870 | |
Shroom expression is attenuated in pulmonary arterial hypertension Sevilla-Perez J., Konigshoff M., Kwapiszewska G., Amarie O. V., Seeger W., Weissmann N., Schermuly R. T., Morty R. E., Eickelberg O. Eur Respir J 2008; 32: 871-880 | |
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension Schermuly R. T., Stasch J-P., Pullamsetti S. S., Middendorff R., Muller D., Schluter K-D., Dingendorf A., Hackemack S., Kolosionek E., Kaulen C., Dumitrascu R., Weissmann N., Mittendorf J., Klepetko W., Seeger W., Ghofrani H. A., Grimminger F. Eur Respir J 2008; 32: 881-891 | |
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome Dambrava P. G., Torres A., Valles X., Mensa J., Marcos M. A., Penarroja G., Camps M., Estruch R., Sanchez M., Menendez R., Niederman M. S. Eur Respir J 2008; 32: 892-901 | |
Can CAP guideline adherence improve patient outcome in internal medicine departments? Blasi F., Iori I., Bulfoni A., Corrao S., Costantino S., Legnani D. Eur Respir J 2008; 32: 902-910 | |
Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis Li M-Y., Yip J., Hsin M. K. Y., Mok T. S. K., Wu Y., Underwood M. J., Chen G. G. Eur Respir J 2008; 32: 911-923 | |
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S-G., Gow C-H., Yu C-J., Chang Y-L., Yang C-H., Hsu Y-C., Shih J-Y., Lee Y-C., Yang P-C. Eur Respir J 2008; 32: 924-930 | |
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD Chappell S., Daly L., Morgan K., Guetta-Baranes T., Roca J., Rabinovich R., Lotya J., Millar A. B., Donnelly S. C., Keatings V., MacNee W., Stolk J., Hiemstra P. S., Miniati M., Monti S., O'Connor C. M., Kalsheker N. Eur Respir J 2008; 32: 931-937 | |
Polymorphic variation in surfactant protein B is associated with COPD exacerbations Foreman M. G., DeMeo D. L., Hersh C. P., Carey V. J., Fan V. S., Reilly J. J., Shapiro S. D., Silverman E. K. Eur Respir J 2008; 32: 938-944 | |
Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Schermer T. R. J., Smeele I. J. M., Thoonen B. P. A., Lucas A. E. M., Grootens J. G., van Boxem T. J., Heijdra Y. F., van Weel C. Eur Respir J 2008; 32: 945-952 | |
Predictors of outcomes in COPD exacerbation cases presenting to the emergency department Roche N., Zureik M., Soussan D., Neukirch F., Perrotin D., the Urgence BPCO (COPD Emergency) Scientific Committee, investigators Eur Respir J 2008; 32: 953-961 | |
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Mannino D. M., Thorn D., Swensen A., Holguin F. Eur Respir J 2008; 32: 962-969 | |
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Southam D. S., Ellis R., Wattie J., Young S., Inman M. D. Eur Respir J 2008; 32: 970-978 | |
Outdoor swimming pools and the risks of asthma and allergies during adolescence Bernard A., Nickmilder M., Voisin C. Eur Respir J 2008; 32: 979-988 | |
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function Rytila P., Ghaly L., Varghese S., Chung W., Selroos O., Haahtela T., on behalf of the Airway Inflammation Study group Eur Respir J 2008; 32: 989-996 | |
Workplace-specific challenges as a contribution to the diagnosis of occupational asthma Rioux J-P., Malo J-L., L'Archeveque J., Rabhi K., Labrecque M. Eur Respir J 2008; 32: 997-1003 | |
Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression Molina-Molina M., Xaubet A., Li X., Abdul-Hafez A., Friderici K., Jernigan K., Fu W., Ding Q., Pereda J., Serrano-Mollar A., Casanova A., Rodriguez-Becerra E., Morell F., Ancochea J., Picado C., Uhal B. D. Eur Respir J 2008; 32: 1004-1008 | |
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Arias M. A., Garcia-Rio F., Alonso-Fernandez A., Hernanz A., Hidalgo R., Martinez-Mateo V., Bartolome S., Rodriguez-Padial L. Eur Respir J 2008; 32: 1009-1015 | |
Clinical and polygraphic evolution of sleep-related breathing disorders in adolescents Sanchez-Armengol A., Ruiz-Garcia A., Carmona-Bernal C., Botebol-Benhamou G., Garcia-Diaz E., Polo-Padillo J., Lopez-Campos J. L., Capote F. Eur Respir J 2008; 32: 1016-1022 | |
Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey Bothamley G. H., Ditiu L., Migliori G. B., Lange C., TBNET contributors Eur Respir J 2008; 32: 1023-1030 | |
Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis Kim D. K., Kim H. J., Kwon S-Y., Yoon H-I., Lee C-T., Kim Y. W., Chung H. S., Han S. K., Shim Y-S., Lee J-H. Eur Respir J 2008; 32: 1031-1036 | |
Effects of glucocorticoids in ventilated piglets with severe pneumonia Sibila O., Luna C. M., Agusti C., Baquero S., Gando S., Patron J. R., Morato J. G., Absi R., Bassi N., Torres A. Eur Respir J 2008; 32: 1037-1046 | |
Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids Holme J., Tomlinson J. W., Stockley R. A., Stewart P. M., Barlow N., Sullivan A. L. Eur Respir J 2008; 32: 1047-1052 | |
Accuracy and reliability of pulse oximetry at different arterial carbon dioxide pressure levels Munoz X., Torres F., Sampol G., Rios J., Marti S., Escrich E. Eur Respir J 2008; 32: 1053-1059 | |
Validation of a single-channel airflow monitor for screening of sleep-disordered breathing Nakano H., Tanigawa T., Ohnishi Y., Uemori H., Senzaki K., Furukawa T., Nishima S. Eur Respir J 2008; 32: 1060-1067 | |
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases Burgel P-R., Nadel J. A. Eur Respir J 2008; 32: 1068-1081 | |
Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives Levy P., Pepin J-L., Arnaud C., Tamisier R., Borel J-C., Dematteis M., Godin-Ribuot D., Ribuot C. Eur Respir J 2008; 32: 1082-1095 | |
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach Brand P. L. P., Baraldi E., Bisgaard H., Boner A. L., Castro-Rodriguez J. A., Custovic A., de Blic J., de Jongste J. C., Eber E., Everard M. L., Frey U., Gappa M., Garcia-Marcos L., Grigg J., Lenney W., Le Souef P., McKenzie S., Merkus P. J. F. M., Midulla F., Paton J. Y., Piacentini G., Pohunek P., Rossi G. A., Seddon P., Silverman M., Sly P. D., Stick S., Valiulis A., van Aalderen W. M. C., Wildhaber J. H., Wennergren G., Wilson N., Zivkovic Z., Bush A. Eur Respir J 2008; 32: 1096-1110 | |
Occupational asthma caused by Arabidopsis thaliana: a case of laboratory plant allergy Yates B., De Soyza A., Harkawat R., Stenton C. Eur Respir J 2008; 32: 1111-1112 | |
Lung hyperinflation: foe or friend? Eichinger M., Walterspacher S., Scholz T., Tetzlaff K., Rocker K., Muth C-M., Puderbach M., Kauczor H-U., Sorichter S., for the breath-hold diving study group of Baden-Wurttemberg Eur Respir J 2008; 32: 1113-1116 | |
Passive smoking and asthma death Invernizzi G., Boffi R., Ruprecht A., Lazzaro A., Fabbri L. M. Eur Respir J 2008; 32: 1117 | |
Asymptomatic airway hyperresponsiveness: what does it mean? Boulet L-P. Eur Respir J 2008; 32: 1118-1119 | |
The effect of inhaled lidocaine-hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis Duong M., Wilson A. M., Jayaram L., Dolovich M., Hargreave F. Eur Respir J 2008; 32: 1119-1122 | |
Dental units as infection sources of Pseudomonas aeruginosa Barben J., Schmid J. Eur Respir J 2008; 32: 1122-1123 | |
Impact of poor dental health on pneumonia Wise M. P., Williams D. W., Lewis M. A., Thomas J. G., Frost P. J. Eur Respir J 2008; 32: 1122 | |
Reproducibility of exhaled breath condensate markers Chow S., Yates D. H., Thomas P. S. Eur Respir J 2008; 32: | |
Exhaled breath condensate is not suitable to detect EGFR somatic mutations Paradiso A., Tommasi S., Pinto R., Carpagnano G. E., Foschino-Barbaro M. P. Eur Respir J 2008; 32: 1123-1124 | |
The potential for patient-led COPD admission avoidance schemes Iwuji C., Rosich-Medina A., Swaminathan N., Baguley D., Kirwin C., Austin K., Kurukulaaratchy R. J. Eur Respir J 2008; 32: 1124-1126 | |
Relationship between depression and exacerbations in COPD: a response Laurin C., Lavoie K. L., Bacon S. L. Eur Respir J 2008; 32: 1126-1127 | |
Inhibition of the renin-angiotensin system in severe COPD Mascitelli L., Pezzetta F., Goldstein M. R. Eur Respir J 2008; 32: 1128-1129 | |
From the authors Calverley P. M. A., Albert P. Eur Respir J 2008; 32: 1129-1130 | |
Mortality predictive capacity of the 6-min walk distance Riario Sforza G. G., Incorvaia C. Eur Respir J 2008; 32: 1130 | |
From the authors Cote C. G. Eur Respir J 2008; 32: 1131 | |